Published in N Engl J Med on July 01, 2004
Microsporidiosis: current status. Curr Opin Infect Dis (2006) 2.81
Zoonotic potential of the microsporidia. Clin Microbiol Rev (2005) 2.76
Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev (2008) 1.66
The microsporidian polar tube: a highly specialised invasion organelle. Int J Parasitol (2005) 1.28
New models of microsporidiosis: infections in Zebrafish, C. elegans, and honey bee. PLoS Pathog (2011) 1.03
Tubulinosema sp. microsporidian myositis in immunosuppressed patient. Emerg Infect Dis (2011) 1.01
Microsporidia - Emergent Pathogens in the Global Food Chain. Trends Parasitol (2016) 0.98
A review of the development of two types of human skeletal muscle infections from microsporidia associated with pathology in invertebrates and cold-blooded vertebrates. Folia Parasitol (Praha) (2005) 0.94
Acquisition of an animal gene by microsporidian intracellular parasites. Curr Biol (2011) 0.94
Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis. Folia Parasitol (Praha) (2005) 0.94
Opportunistic nature of the mammalian microsporidia: experimental transmission of Trachipleistophora extenrec (Fungi: Microsporidia) between mammalian and insect hosts. Parasitol Res (2010) 0.90
Annotation of microsporidian genomes using transcriptional signals. Nat Commun (2012) 0.90
InterB multigenic family, a gene repertoire associated with subterminal chromosome regions of Encephalitozoon cuniculi and conserved in several human-infecting microsporidian species. Curr Genet (2007) 0.89
An analysis of the microsporidian genus Brachiola, with comparisons of human and insect isolates of Brachiola algerae. J Eukaryot Microbiol (2005) 0.88
Animal cell cultures in microsporidial research: their general roles and their specific use for fish microsporidia. In Vitro Cell Dev Biol Anim (2009) 0.86
A role for antimicrobial peptides in intestinal microsporidiosis. Parasitology (2008) 0.86
Human vocal cord infection with the Microsporidium Anncaliia algerae. J Eukaryot Microbiol (2010) 0.85
Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470. Mol Biochem Parasitol (2009) 0.85
Disseminated infection caused by novel species of Microsporidium, Thailand. Emerg Infect Dis (2012) 0.84
Anncaliia algerae microsporidial myositis. Emerg Infect Dis (2014) 0.82
Microsporidia: Horizontal gene transfers in vicious parasites. Mob Genet Elements (2011) 0.81
Why the International Workshops on Opportunistic Protists? Eukaryot Cell (2009) 0.80
Analysis of the beta-tubulin gene and morphological changes of the microsporidium Anncaliia algerae both suggest albendazole sensitivity. J Eukaryot Microbiol (2014) 0.79
Parasitic infections and myositis. Parasitol Res (2011) 0.79
Effects of host temperature and gastric and duodenal environments on microsporidia spore germination and infectivity of intestinal epithelial cells. Parasitol Res (2008) 0.79
Gastrointestinal cell mediated immunity and the microsporidia. PLoS Pathog (2012) 0.77
System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae. Antimicrob Agents Chemother (2006) 0.77
Nonbacterial myositis. Curr Infect Dis Rep (2010) 0.75
Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and Albendazole. Open Forum Infect Dis (2016) 0.75
Microsporidium Infecting Anopheles supepictus (Diptera: Culicidae) Larvae. J Arthropod Borne Dis (2016) 0.75
Subtelomere organization in the genome of the microsporidian Encephalitozoon cuniculi: patterns of repeated sequences and physicochemical signatures. BMC Genomics (2016) 0.75
Microsporidia: Obligate Intracellular Pathogens Within the Fungal Kingdom. Microbiol Spectr (2017) 0.75
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med (2001) 18.25
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med (2000) 16.20
Human microsporidial infections. Clin Microbiol Rev (1994) 4.66
A mitochondrial remnant in the microsporidian Trachipleistophora hominis. Nature (2002) 2.98
Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum (2002) 2.12
Enterocytozoon bieneusi as a cause of chronic diarrhea in a heart-lung transplant recipient who was seronegative for human immunodeficiency virus. Clin Infect Dis (1996) 1.98
Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. J Immunol (1996) 1.43
Microsporidiosis myositis in a patient with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.39
Disseminated microsporidiosis in a renal transplant recipient. Transpl Infect Dis (2002) 1.14
Intestinal microsporidiosis occurring in a liver transplant recipient. Transplantation (1995) 1.14
Myositis due to Pleistophora (Microsporidia) in a patient with AIDS. Clin Infect Dis (1993) 1.11
Corneal microsporidioses: characterization and identification. J Protozool (1992) 1.10
Isolation of Nosema algerae from the cornea of an immunocompetent patient. J Eukaryot Microbiol (1999) 1.09
Microsporidia infection in transplant patients. Transplantation (1999) 1.06
Brachiola vesicularum, n. g., n. sp., a new microsporidium associated with AIDS and myositis. J Eukaryot Microbiol (1998) 1.05
The effects of elevated temperatures and various time-temperature combinations on the development of Brachiola (Nosema) algerae N. Comb. in mammalian cell culture. J Eukaryot Microbiol (2000) 1.04
In vitro cultivation of microsporidia of clinical importance. Clin Microbiol Rev (2002) 1.04
Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection. Infect Immun (1999) 1.04
Immune response to Encephalitozoon cuniculi infection. Microbes Infect (2001) 1.03
Ultrastructure and development of Pleistophora ronneafiei n. sp., a microsporidium (Protista) in the skeletal muscle of an immune-compromised individual. J Eukaryot Microbiol (2003) 1.03
Nosema algerae n. sp. (Cnidospora, Microsporida) a pathogen in a laboratory colony of Anopheles stephensi Liston (Diptera, Culicidae). J Protozool (1970) 1.02
Pneumocystis carinii pneumonia following a second infusion of infliximab. Rheumatology (Oxford) (2002) 0.97
Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS. J Clin Microbiol (1996) 0.94
Thalidomide: a novel therapy for microsporidiosis. Gastroenterology (1997) 0.93
Microsporidiosis in the graft of a renal transplant recipient. Transpl Int (2001) 0.92
Mosquito (Diptera: Culicidae) host compatibility and vector competency for the human myositic parasite Trachipleistophora hominis (Phylum Microspora). J Med Entomol (1999) 0.92
The human isolate of Brachiola algerae (Phylum Microspora): development in SCID mice and description of its fine structure features. Parasitology (2001) 0.90
Tuberculosis and treatment with infliximab. N Engl J Med (2002) 0.89
Molecular phylogeny and diagnostic approaches to microsporidia. Contrib Microbiol (2000) 0.87
In vitro replication of Nosema algerae (Microsporidia), a parasite of anopheline mosquitoes, in human cells above 36 degrees C. J Eukaryot Microbiol (1999) 0.86
IFN-gamma and LPS induce murine macrophages to kill Encephalitozoon cuniculi in vitro. J Eukaryot Microbiol (1995) 0.85
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20
Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell (2010) 4.47
Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev (2011) 3.45
Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol (2004) 3.20
Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA (2013) 3.06
Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal. J Clin Microbiol (2003) 3.03
Unique endemicity of cryptosporidiosis in children in Kuwait. J Clin Microbiol (2005) 2.84
Microsporidiosis: current status. Curr Opin Infect Dis (2006) 2.81
Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol (2002) 2.75
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol (2006) 2.37
Distribution of cryptosporidium genotypes in storm event water samples from three watersheds in New York. Appl Environ Microbiol (2005) 2.27
Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int (2002) 2.24
Malignant Transformation of Hymenolepis nana in a Human Host. N Engl J Med (2015) 2.21
Cryptosporidium tyzzeri n. sp. (Apicomplexa: Cryptosporidiidae) in domestic mice (Mus musculus). Exp Parasitol (2011) 2.16
Molecular characterization of microsporidia indicates that wild mammals Harbor host-adapted Enterocytozoon spp. as well as human-pathogenic Enterocytozoon bieneusi. Appl Environ Microbiol (2003) 2.15
Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res (2010) 2.11
Toxoplasma gondii: the model apicomplexan. Int J Parasitol (2004) 2.10
Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg Infect Dis (2002) 2.04
Blastocystis: to treat or not to treat... Clin Infect Dis (2011) 2.01
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Identification of novel Cryptosporidium genotypes from the Czech Republic. Appl Environ Microbiol (2003) 1.93
Identification and distribution of Acanthamoeba species genotypes associated with nonkeratitis infections. J Clin Microbiol (2005) 1.89
Caveolin-1 null mice develop cardiac hypertrophy with hyperactivation of p42/44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol (2002) 1.86
The adipocyte as an important target cell for Trypanosoma cruzi infection. J Biol Chem (2005) 1.82
Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis (2011) 1.77
Molecular epidemiology of cryptosporidiosis in children in Malawi. J Eukaryot Microbiol (2003) 1.75
Prevalence and age-related variation of Cryptosporidium species and genotypes in dairy calves. Vet Parasitol (2004) 1.75
Genomic survey of the non-cultivatable opportunistic human pathogen, Enterocytozoon bieneusi. PLoS Pathog (2009) 1.73
Opportunistic amoebae: challenges in prophylaxis and treatment. Drug Resist Updat (2004) 1.68
Development of procedures for direct extraction of Cryptosporidium DNA from water concentrates and for relief of PCR inhibitors. Appl Environ Microbiol (2005) 1.68
Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation. J Proteome Res (2010) 1.64
Molecular confirmation of Sappinia pedata as a causative agent of amoebic encephalitis. J Infect Dis (2009) 1.63
Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis (2009) 1.60
Molecular surveillance of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi by genotyping and subtyping parasites in wastewater. PLoS Negl Trop Dis (2012) 1.60
Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin Infect Dis (2003) 1.57
Molecular phylogeny and evolutionary relationships of Cryptosporidium parasites at the actin locus. J Parasitol (2002) 1.56
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. Clin Infect Dis (2009) 1.54
Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis (2007) 1.53
Multilocus sequence typing and genetic structure of Cryptosporidium hominis from children in Kolkata, India. Infect Genet Evol (2006) 1.52
Wide geographic distribution of Cryptosporidium bovis and the deer-like genotype in bovines. Vet Parasitol (2006) 1.51
Zoonotic Cryptosporidium species and Enterocytozoon bieneusi genotypes in HIV-positive patients on antiretroviral therapy. J Clin Microbiol (2012) 1.51
Microsporidiosis acquired through solid organ transplantation: a public health investigation. Ann Intern Med (2014) 1.50
Molecular characterization of Enterocytozoon bieneusi in cattle indicates that only some isolates have zoonotic potential. Parasitol Res (2004) 1.47
Molecular surveillance of Cryptosporidium spp. in raw wastewater in Milwaukee: implications for understanding outbreak occurrence and transmission dynamics. J Clin Microbiol (2003) 1.46
Mechanisms of Trypanosoma cruzi persistence in Chagas disease. Cell Microbiol (2012) 1.45
Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol (2002) 1.43
Primary amebic meningoencephalitis deaths associated with sinus irrigation using contaminated tap water. Clin Infect Dis (2012) 1.41
Epidemiology of Enterocytozoon bieneusi Infection in Humans. J Parasitol Res (2012) 1.41
Concurrent infections of Giardia duodenalis, Enterocytozoon bieneusi, and Clostridium difficile in children during a cryptosporidiosis outbreak in a pediatric hospital in China. PLoS Negl Trop Dis (2013) 1.41
Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection. Eukaryot Cell (2011) 1.40
Cryptosporidium genotypes in wildlife from a new york watershed. Appl Environ Microbiol (2007) 1.39
Giardiasis in dogs and cats: update on epidemiology and public health significance. Trends Parasitol (2010) 1.39
Direct comparison of selected methods for genetic categorisation of Cryptosporidium parvum and Cryptosporidium hominis species. Int J Parasitol (2005) 1.38
Genetic diversity of Cryptosporidium spp. in cattle in Michigan: implications for understanding the transmission dynamics. Parasitol Res (2003) 1.37
Identification of the cryptosporidium pig genotype in a human patient. J Infect Dis (2002) 1.36
National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis (2009) 1.36
In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol (2006) 1.35
Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. J Clin Microbiol (2003) 1.35
Cryptosporidium sp. rabbit genotype, a newly identified human pathogen. Emerg Infect Dis (2009) 1.35
Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A (2011) 1.34
Chagas disease has now gone global. PLoS Negl Trop Dis (2011) 1.34
Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.34
Host cell autophagy is induced by Toxoplasma gondii and contributes to parasite growth. J Biol Chem (2008) 1.34
Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal. Parasitol Res (2006) 1.34
The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis (2005) 1.33
Genetic characterizations of Cryptosporidium spp. and Giardia duodenalis in humans in Henan, China. Exp Parasitol (2010) 1.32
Caveolin-1 null (-/-) mice show dramatic reductions in life span. Biochemistry (2003) 1.31
The reduced genome of the parasitic microsporidian Enterocytozoon bieneusi lacks genes for core carbon metabolism. Genome Biol Evol (2010) 1.30
Extended outbreak of cryptosporidiosis in a pediatric hospital, China. Emerg Infect Dis (2012) 1.30
The microsporidian polar tube: a highly specialised invasion organelle. Int J Parasitol (2005) 1.28
Cyclospora papionis, Cryptosporidium hominis, and human-pathogenic Enterocytozoon bieneusi in captive baboons in Kenya. J Clin Microbiol (2011) 1.28
Subtyping Cryptosporidium ubiquitum,a zoonotic pathogen emerging in humans. Emerg Infect Dis (2014) 1.28
A molecular biologic study of Enterocytozoon bieneusi in HIV-infected patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.27
Genotyping of Balamuthia mandrillaris based on nuclear 18S and mitochondrial 16S rRNA genes. Am J Trop Med Hyg (2003) 1.27
Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study. Int J Parasitol (2002) 1.27
Cryptosporidiosis in developing countries. J Infect Dev Ctries (2007) 1.27
Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease. Semin Immunopathol (2012) 1.26
Occurrence of human-pathogenic Enterocytozoon bieneusi, Giardia duodenalis and Cryptosporidium genotypes in laboratory macaques in Guangxi, China. Parasitol Int (2013) 1.25
Anthroponotic enteric parasites in monkeys in public park, China. Emerg Infect Dis (2012) 1.25
Genetic variations in the internal transcribed spacer and mitochondrial small subunit rRNA gene of Naegleria spp. J Eukaryot Microbiol (2003) 1.24
Distribution of Giardia duodenalis genotypes and subgenotypes in raw urban wastewater in Milwaukee, Wisconsin. Appl Environ Microbiol (2004) 1.24
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res (2012) 1.24
Detection and differentiation of Cryptosporidium parasites that are pathogenic for humans by real-time PCR. J Clin Microbiol (2002) 1.23
Genetic polymorphism and zoonotic potential of Enterocytozoon bieneusi from nonhuman primates in China. Appl Environ Microbiol (2014) 1.22
Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J Exp Med (2007) 1.21
Transmission of Enterocytozoon bieneusi between a child and guinea pigs. J Clin Microbiol (2007) 1.21
Cryptosporidium genotype and subtype distribution in raw wastewater in Shanghai, China: evidence for possible unique Cryptosporidium hominis transmission. J Clin Microbiol (2008) 1.21
Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res (2003) 1.19
Amebic encephalitis caused by Balamuthia mandrillaris: report of four cases. Pediatr Infect Dis J (2003) 1.19
Comparison of real-time PCR protocols for differential laboratory diagnosis of amebiasis. J Clin Microbiol (2005) 1.18
Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine. Emerg Infect Dis (2008) 1.17
Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion. PLoS Negl Trop Dis (2011) 1.17
Induction of a rapid and strong antigen-specific intraepithelial lymphocyte response during oral Encephalitozoon cuniculi infection. J Immunol (2004) 1.17
Genotypes and subtypes of Cryptosporidium spp. in neonatal calves in Northern Ireland. Parasitol Res (2006) 1.17